LSTA
LSTA
NASDAQ · Biotechnology

Lisata Therapeutics Inc

$4.54
-0.06 (-1.30%)
As of Feb 8, 2:20 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 5.32M 5.21M 4.72M
Net Income -175,194 -195,079 -179,711
EPS
Profit Margin -3.3% -3.8% -3.8%
Rev Growth +3.4% -0.3% +24.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 17.62M 21.25M 18.39M
Total Equity 11.57M 13.67M 13.06M
D/E Ratio 1.52 1.55 1.41
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -241,242 -244,954 -200,080
Free Cash Flow -156,086 -167,798 -115,643